These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22908157)

  • 1. Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway.
    Sampson TR; Liu X; Schroeder MR; Kraft CS; Burd EM; Weiss DS
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5642-9. PubMed ID: 22908157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review of Antimicrobial Resistance of Clinical Acinetobacter baumannii Isolates in Iran: An Update.
    Razavi Nikoo H; Ardebili A; Mardaneh J
    Microb Drug Resist; 2017 Sep; 23(6):744-756. PubMed ID: 28085571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance.
    Cheah SE; Li J; Tsuji BT; Forrest A; Bulitta JB; Nation RL
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3921-33. PubMed ID: 27067324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyxins retain
    Rubio J; Yan J; Miller S; Cheng J; Li R; Builta Z; Aoyagi K; Fisher M; She R; Spellberg B; Luna B
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0072524. PubMed ID: 39240097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
    J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
    Thomas VM; Brown RM; Ashcraft DS; Pankey GA
    Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
    Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
    J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative metabolomics reveals key pathways associated with the synergistic activity of polymyxin B and rifampicin combination against multidrug-resistant Acinetobacter baumannii.
    Zhao J; Han ML; Zhu Y; Lin YW; Wang YW; Lu J; Hu Y; Tony Zhou Q; Velkov T; Li J
    Biochem Pharmacol; 2021 Feb; 184():114400. PubMed ID: 33387481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Evaluation of Broth Microdilution with Polystyrene and Glass-Coated Plates, Agar Dilution, E-Test, Vitek, and Disk Diffusion for Susceptibility Testing of Colistin and Polymyxin B on Carbapenem-Resistant Clinical Isolates of Acinetobacter baumannii.
    Singhal L; Sharma M; Verma S; Kaur R; Britto XB; Kumar SM; Ray P; Gautam V
    Microb Drug Resist; 2018 Oct; 24(8):1082-1088. PubMed ID: 29406804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performances of the Rapid Polymyxin
    Lescat M; Poirel L; Jayol A; Nordmann P
    Microb Drug Resist; 2019 May; 25(4):520-523. PubMed ID: 30508392
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
    Akin FE; Bayram A; Balci I
    Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens.
    Cheah SE; Johnson MD; Zhu Y; Tsuji BT; Forrest A; Bulitta JB; Boyce JD; Nation RL; Li J
    Sci Rep; 2016 May; 6():26233. PubMed ID: 27195897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin Dependence in Extensively Drug-Resistant
    Chamoun S; Welander J; Martis-Thiele MM; Ntzouni M; Claesson C; Vikström E; Turkina MV
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii.
    Bian X; Liu X; Feng M; Bergen PJ; Li J; Chen Y; Zheng H; Song S; Zhang J
    Int J Antimicrob Agents; 2021 Feb; 57(2):106271. PubMed ID: 33352235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains.
    Lo-Ten-Foe JR; de Smet AM; Diederen BM; Kluytmans JA; van Keulen PH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3726-30. PubMed ID: 17646414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the arsenal for multidrug-resistant Acinetobacter infections: polymyxin antibiotics.
    Kassamali Z; Jain R; Danziger LH
    Int J Infect Dis; 2015 Jan; 30():125-32. PubMed ID: 25461655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of in vitro synergy between polymyxin B or colistin in combination with 16 antimicrobial agents against multidrug-resistant Acinetobacter baumannii isolates.
    Wang Y; Ma Y; Xiong L; Wang X; Zhou Y; Chi X; Chen T; Fu H; Luo Q; Xiao Y
    J Microbiol Immunol Infect; 2024 Apr; 57(2):300-308. PubMed ID: 38350840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies.
    Rao GG; Ly NS; Bulitta JB; Soon RL; San Roman MD; Holden PN; Landersdorfer CB; Nation RL; Li J; Forrest A; Tsuji BT
    J Antimicrob Chemother; 2016 Nov; 71(11):3148-3156. PubMed ID: 27494922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.